Literature DB >> 17950399

Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration.

Ji-jing Pang1, Amanda Lauramore, Wen-tao Deng, Qiuhong Li, Thomas J Doyle, Vince Chiodo, Jie Li, William W Hauswirth.   

Abstract

The specificity of retinal cells transduced by AAV serotype 1, 2 or 5 vectors was determined in vivo versus in vitro in the normal P7 mouse in order to develop a rapid and accurate way to anticipate the behavior of AAV vectors in the retina. In vivo results confirm that AAV1 transduces retinal pigment epithelial cells, while AAV2 and AAV5 transduce both RPE and photoreceptor cells by subretinal injection. AAV2 was the only serotype to efficiently transduce inner retinal cells by intravitreal injection. Parallel analysis employing in vitro retinal organ culture showed qualitatively similar AAV-mediated GFP expression as seen in vivo suggesting that organ culture substitute is a useful method to screen new vector transduction patterns, particular in retinal cells in neonatal mice.

Entities:  

Mesh:

Year:  2007        PMID: 17950399     DOI: 10.1016/j.visres.2007.08.009

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  42 in total

1.  XIAP therapy increases survival of transplanted rod precursors in a degenerating host retina.

Authors:  Jingyu Yao; Kecia L Feathers; Hemant Khanna; Debra Thompson; Catherine Tsilfidis; William W Hauswirth; John R Heckenlively; Anand Swaroop; David N Zacks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

2.  Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats.

Authors:  Wen-Tao Deng; Astra Dinculescu; Qiuhong Li; Sanford L Boye; Jie Li; Marina S Gorbatyuk; Jijing Pang; Vince A Chiodo; Michael T Matthes; Douglas Yasumura; Li Liu; Fowzan S Alkuraya; Kang Zhang; Douglas Vollrath; Matthew M LaVail; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-06       Impact factor: 4.799

3.  Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.

Authors:  J Pang; S E Boye; B Lei; S L Boye; D Everhart; R Ryals; Y Umino; B Rohrer; J Alexander; J Li; X Dai; Q Li; B Chang; R Barlow; W W Hauswirth
Journal:  Gene Ther       Date:  2010-03-18       Impact factor: 5.250

Review 4.  AAV-mediated gene therapy in mouse models of recessive retinal degeneration.

Authors:  J-J Pang; L Lei; X Dai; W Shi; X Liu; A Dinculescu; J H McDowell
Journal:  Curr Mol Med       Date:  2012-03       Impact factor: 2.222

5.  LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile.

Authors:  Rajeshwari Koilkonda; Hong Yu; Venu Talla; Vittorio Porciatti; William J Feuer; William W Hauswirth; Vince Chiodo; Kirsten E Erger; Sanford L Boye; Alfred S Lewin; Thomas J Conlon; Lauren Renner; Martha Neuringer; Carol Detrisac; John Guy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-23       Impact factor: 4.799

6.  rAAV2/5 gene-targeting to rods:dose-dependent efficiency and complications associated with different promoters.

Authors:  W A Beltran; S L Boye; S E Boye; V A Chiodo; A S Lewin; W W Hauswirth; G D Aguirre
Journal:  Gene Ther       Date:  2010-04-29       Impact factor: 5.250

7.  AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation.

Authors:  Ji-Jing Pang; Sanford L Boye; Ashok Kumar; Astra Dinculescu; Wentao Deng; Jie Li; Qiuhong Li; Asha Rani; Thomas C Foster; Bo Chang; Norman L Hawes; Jeffrey H Boatright; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-27       Impact factor: 4.799

8.  Cone phosphodiesterase-6α' restores rod function and confers distinct physiological properties in the rod phosphodiesterase-6β-deficient rd10 mouse.

Authors:  Wen-Tao Deng; Keisuke Sakurai; Saravanan Kolandaivelu; Alexander V Kolesnikov; Astra Dinculescu; Jie Li; Ping Zhu; Xuan Liu; Jijing Pang; Vince A Chiodo; Sanford L Boye; Bo Chang; Visvanathan Ramamurthy; Vladimir J Kefalov; William W Hauswirth
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

Review 9.  The use of canine models of inherited retinal degeneration to test novel therapeutic approaches.

Authors:  William A Beltran
Journal:  Vet Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.644

10.  Evaluation of the adeno-associated virus mediated long-term expression of channelrhodopsin-2 in the mouse retina.

Authors:  Elena Ivanova; Zhuo-Hua Pan
Journal:  Mol Vis       Date:  2009-08-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.